{"published": "2015-09-09T21:07:57Z", "media-type": "News", "title": "Leishmaniasis (Kala-Azar) Global Clinical Trials Review 2015 Market Size, Share, Trend, Analysis, Research Report", "id": "367c084d-7c2c-480f-a969-c2cd3819eb0a", "content": "This press release was orginally distributed by SBWire\n\nDeerfield Beach, FL -- (SBWIRE) -- 09/09/2015 -- Clinical trial report, Review, H1, 2015 Market Size , Share , Trend , Analysis , Research Report provides an overview of Leishmaniasis (Kala-Azar) clinical trials scenario. This report provides top line data relating to the clinical trials on Leishmaniasis (Kala-Azar). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. \n\nRequest For Sample Report Here: \n\nhttp://www.marketresearchstore.com/report/leishmaniasis-global-clinical-trials-review-h1-2015-21382#requestSample\n\nReport also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.\n\nThe report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.\n\nScope\n\nThe report provides a snapshot of the global clinical trials landscape\n\nReport provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status\n\nThe report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company\n\nThe report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment\n\nThe Report provides enrollment trends for the past five years\n\nReport provides latest news for the past three months\n\nReasons to buy\n\nAssists in formulating key business strategies with regards to investment\n\nHelps in identifying prominent locations for conducting clinical trials which saves time and cost\n\nProvides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities\n\nSupports understanding of trials count and enrollment trends by country in global therapeutics market\n\nAids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials\n\nFacilitates clinical trial assessment of the indication on a global, regional and country level\n\nFor more information on this press release visit: http://www.sbwire.com/press-releases/leishmaniasis-kala-azar-global-clinical-trials-review-2015-market-size-share-trend-analysis-research-report-623746.htm\n\nJoel John\n\nCorporate Sales Specialist\n\nMarket Research Store\n\nTelephone: +1-855-465-4651Email: Web: http://www.marketresearchstore.com/report/leishmaniasis-global-clinical-trials-review-h1-2015-21382", "source": "Digital Journal"}